
### [NCIT:C4107](http://purl.obolibrary.org/obo/NCIT_C4107)
**Label:** Nasopharyngeal Type Undifferentiated Carcinoma

**Subclasses:** [NCIT:C8229](http://purl.obolibrary.org/obo/NCIT_C8229) (Stage IV Nasopharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C8227](http://purl.obolibrary.org/obo/NCIT_C8227) (Stage III Nasopharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C7998](http://purl.obolibrary.org/obo/NCIT_C7998) (Thymic Lymphoepithelioma-Like Carcinoma), [NCIT:C8225](http://purl.obolibrary.org/obo/NCIT_C8225) (Stage II Nasopharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C6035](http://purl.obolibrary.org/obo/NCIT_C6035) (Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8), [NCIT:C8223](http://purl.obolibrary.org/obo/NCIT_C8223) (Stage I Nasopharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C115089](http://purl.obolibrary.org/obo/NCIT_C115089) (Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C115088](http://purl.obolibrary.org/obo/NCIT_C115088) (Stage III Oropharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C115087](http://purl.obolibrary.org/obo/NCIT_C115087) (Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7), [NCIT:C8023](http://purl.obolibrary.org/obo/NCIT_C8023) (Nasopharyngeal Undifferentiated Carcinoma), [NCIT:C115086](http://purl.obolibrary.org/obo/NCIT_C115086) (Stage I Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7), [NCIT:C8231](http://purl.obolibrary.org/obo/NCIT_C8231) (Recurrent Nasopharyngeal Undifferentiated Carcinoma), [NCIT:C115093](http://purl.obolibrary.org/obo/NCIT_C115093) (Recurrent Oropharyngeal Undifferentiated Carcinoma), [NCIT:C45519](http://purl.obolibrary.org/obo/NCIT_C45519) (Lymphoepithelioma-Like Lung Carcinoma), [NCIT:C39885](http://purl.obolibrary.org/obo/NCIT_C39885) (Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant), [NCIT:C68610](http://purl.obolibrary.org/obo/NCIT_C68610) (Oropharyngeal Undifferentiated Carcinoma), [NCIT:C40193](http://purl.obolibrary.org/obo/NCIT_C40193) (Cervical Lymphoepithelioma-Like Carcinoma), [NCIT:C35736](http://purl.obolibrary.org/obo/NCIT_C35736) (Salivary Gland Lymphoepithelial Carcinoma), [NCIT:C39821](http://purl.obolibrary.org/obo/NCIT_C39821) (Infiltrating Bladder Lymphoepithelioma-Like Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([NCIT:C60664](http://purl.obolibrary.org/obo/NCIT_C60664) (Malignant Epithelial Cell with Vesicular Nucleus, Distinct Nucleolus, and Abundant Pink Cytoplasm))) 66.67%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) 52.02%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([CHEBI:23019](http://purl.obolibrary.org/obo/CHEBI_23019) (carbonyl group))) 52.02%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([CHEBI:23004](http://purl.obolibrary.org/obo/CHEBI_23004) (carbamoyl group))) 52.02%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([CHEBI:22868](http://purl.obolibrary.org/obo/CHEBI_22868) (bile salt))) 52.02%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([CHEBI:22563](http://purl.obolibrary.org/obo/CHEBI_22563) (anion))) 52.02%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([CHEBI:17089](http://purl.obolibrary.org/obo/CHEBI_17089) (glycoprotein))) 52.02%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([CHEBI:16990](http://purl.obolibrary.org/obo/CHEBI_16990) (bilirubin))) 52.02%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([CHEBI:16541](http://purl.obolibrary.org/obo/CHEBI_16541) (protein polypeptide chain))) 52.02%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([CHEBI:16336](http://purl.obolibrary.org/obo/CHEBI_16336) (hyaluronic acid))) 52.02%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([CHEBI:15440](http://purl.obolibrary.org/obo/CHEBI_15440) (squalene))) 52.02%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([CHEBI:10545](http://purl.obolibrary.org/obo/CHEBI_10545) (electron))) 52.02%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not (CARO:0010000)) 52.02%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([BFO:0000020](http://purl.obolibrary.org/obo/BFO_0000020) (null))) 52.02%
- [NCIT:C54387](http://purl.obolibrary.org/obo/NCIT_C54387) (Malignant Epithelial Large Cell with Vesicular Nucleus and Distinct Nucleolus) and (not ([BFO:0000019](http://purl.obolibrary.org/obo/BFO_0000019) (null))) 52.02%


